Literature DB >> 6155298

The effect of aprotinin on the absorption of subcutaneously injected regular insulin in normal subjects.

M Berger, H J Cüppers, P A Halban, R E Offord.   

Abstract

The effect of aprotinin on the absorption of regular insulin was assessed in normal man. Ten units of Actrapid insulin were subcutaneously injected together with 1.4 mg aprotinin (i.e., 0.5 ml of Trasylol) or an equivalent volume of physiologic saline (controls) into the thighs of overnight-fasted normal subjects. Aprotinin caused an increase in the rate of insulin entry into the circulation; the absolute amount of insulin that was detected in the circulation during the course of the experiment was also higher. In addition, the onset of the hypoglycemic action of exogenous insulin was significantly accelerated when insulin was administered together with aprotinin. These data suggest that aprotinin increases the absorption rate of subcutaneously injected insulin from its depot into the circulation, possibly by an inhibition of the local degradation of exogenous insulin at the injection site.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155298     DOI: 10.2337/diab.29.1.81

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

1.  The influence of aprotinin on regional absorption of soluble human insulin.

Authors:  D R Owens; J P Vora; J Birtwell; S Luzio; T M Hayes
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

2.  Site dependence of absorption-promoting actions of laureth-9, Na salicylate, Na2EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery.

Authors:  B J Aungst; N J Rogers
Journal:  Pharm Res       Date:  1988-05       Impact factor: 4.200

3.  Subcutaneous degradation of insulin.

Authors:  R W Stevenson
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

4.  Pharmacokinetic approach for reconstruction of predetermined plasma insulin profiles by continuous subcutaneous insulin infusion in depancreatized dogs.

Authors:  H Hirayama; Y Kasuya; T Kobayashi; T Itoh; A Yagishita; T Katakura; K Isono
Journal:  J Pharmacokinet Biopharm       Date:  1983-12

5.  Subcutaneous degradation of insulin.

Authors:  T Deckert; B Hansen; T Lauritzen; J S Christiansen
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122

6.  Insulin absorption from the abdomen and the thigh in healthy subjects during rest and exercise: blood glucose, plasma insulin, growth hormone, adrenaline and noradrenaline levels.

Authors:  H Süsstrunk; B Morell; W H Ziegler; E R Froesch
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

7.  Insulin responses to varying profiles of subcutaneous insulin infusion: kinetic modelling studies.

Authors:  E W Kraegen; D J Chisholm
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122

8.  Influence of aprotinin on insulin absorption and subcutaneous blood flow in type 1 (insulin-dependent) diabetes.

Authors:  B Linde; R Gunnarsson
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

9.  Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.

Authors:  J C Pickup; P D Home; R W Bilous; H Keen; K G Alberti
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-31

10.  Enhanced bioavailability of subcutaneously injected insulin coadministered with collagen in rats and humans.

Authors:  R Hori; F Komada; S Iwakawa; Y Seino; K Okumura
Journal:  Pharm Res       Date:  1989-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.